Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2005; 51(1): 99-108

Role of the genetic factorsin osteoporosis development

I.N.Pishel, L.N.Pashynyan, G.M.Butenko




Abstract

Osteoporosis which often accompanies the normal aging and a number of pathological conditions is closely related to bone remodeling disturbances. This process is provided mainly by the genesis of osteoblasts and osteoclasts, their activities and interactions. All the above in turn is dependent on numerous systemic and local regulatory factors such as hormones, nutri- ents, minerals, vitamins, cytokines, their receptors etc. Recently the crucial role of genetic polymorphism of many receptors in bone remodeling, bone loss and susceptibility to osteoporosis development has been shown. This review is devoted to the genetic background of interrelationships among the hormones, cytokines, vitamins and their receptors and discussion of pos- sible sources of discrepancies in data obtained by many au- thors who studied populations like genetic, diet, life-styles and environmental influences.

Full text: (PDF, in Ukrainian)

References

  1. Бутенко Г.М. Остеопороз и иммунная система //Пробл. остеології. – 1999. – 2, № 3. – С.23–28.
  2. Поворознюк В.В., Нейко Є.М., Головач І.Ю.Глюкокортикоїдіндукований остеопороз. – К: ТМК. –2002. – 208 с.
  3. Abe E., Tanaka H., Ishimi Y. et. al. Differentiation-inducing factor purified from conditioned medium ofmitogen-treated spleen cell cultures stimulates boneresorbtion // Proc. Natl. Acad. Sci. – 1986. – 83, № 4. –P.5958–5962.
  4. Albagha O.M.E., Tasker P.N., McGuigan F.E.A. et al.Linkage disequilibrium between polymorphisms in thehuman TNFRSF1B gene and their association withbone mass in perimenopausal women // Hum. Mol.Genetics. – 2002. – 11, № 19. – P.2289–2295.
  5. Arai H., Miyamoto K., Taketani Y. et al. A vitamin Dreceptor gene polymorphism in the translation initia-tion codon: effect on protein activity and relation tobone mineral density in Japanese women // J. BoneMiner. Res. – 1997. – 12, № 4. – P.915–921.
  6. Arko B., Preelj J., Komel R. et al. Sequence variationsin the osteoprotegerin gene promoter in patients withpostmenopausal osteoporosis // J. Clin. Endocrinol.Metabolism. – 2002. – 87, № 9. – P.4080–4084.
  7. Bajnok E., Takacs I., Vargha P. et al. Lack of associa-tion between interleukin-1 receptor antagonist proteingene polymorphism and bone mineral density inHungarian postmenopausal women // Bone. – 2000. –27, № 3. – P.559–562.
  8. Balasch J. Sex steroids and bone: current perspectives// Hum. Reprod. Update. – 2003. – 9, № 1. – P.207–222.
  9. 9. Bellamy R., Ruwende C., Corrah T. et al. Tuberculosisand chronic hepatitis B virus infection in Africans andvariation in the vitamin D receptor gene // J. Infect.Dis. – 1999. – 179, № 3. – P.721–724.
  10. 10. Carling T., Ridefelt P., Hellman P. et al. Vitamin Dreceptor polymorphisms correlate to parathyroid cellfunction in primary hyperparathyroidism // J. Clin.Endocrinol. Metab. – 1997. – 82, № 10. – P.1772–1775.
  11. Centrella M., Rosen V., Wozney J.M. et al. Opposingeffects by glucocorticoid and bone morphogenetic pro-tein-2 in fetal rat bone cell cultures // J. Cell Biochem. –1997. – 67, № 2 – P.528–540.
  12. Cheleuitte D., Mizuno S., Glowacki J. In vitro secre-tion of cytokines by human bone marrow: effects ofage and estrogen status // J. Clin. Endocrinol. Metab. –1998. – 83, № 11 – P.2043–2051.
  13. Costa A.F.P, dos Reis L.M., Ribeiro M.C. et al. Ef-fects of calcitriol on parathyroid function and on boneremodelling in secondary hyperparathyroidism //Nephrol. Dial. Transplant. – 2003. – 18, № 2 – P.743–749.
  14. Crofts L., Hancock M., Morrison N., Eisman J. Mul-tiple promoters direct the tissue-specific expressionof novel N-terminal variant human vitamin D receptorgene transcripts // Proc. Natl. Acad. Sci. USA. – 1998. –95, № 10. – P.10529–10534.
  15. Cummings S.R., Nevitt M.C., Browner W.S. et al. Riskfactors for hip fracture in white women. Study of Os-teoporotic Fractures Research Group // N. Engl. J. Med. –1995. – 332, № 3. – P.767–773.
  16. Devoto M., Shimoya K., Caminis J. et al. First-stageautosomal genome screen in extended pedigrees sug-gests genes predisposing to low bone mineral densityon chromosomes 1p, 2p and 4q // Eur. J. Hum. Genet. –1998. – 6, № 1. – P.151–157.
  17. Donath J., Speer G., Poor G. et al. Vitamin D receptor,oestrogen receptor-{alpha} and calcium-sensingreceptor genotypes, bone mineral density and biochemi-cal markers in Paget’s disease of bone // Rheumatology. –2004. – 43, № 6. – P.692–695.
  18. Duncan E.L., Brown M.A., Sinsheimer J. et al. Suggestivelinkage of the parathyroid receptor type 1 to osteoporosis// J. Bone Miner. Res. – 1999. – 14, № 12. – P.1993–1999.
  19. 19. Eccleshall T.R., Garnero P., Gross C. et al. Lack ofcorrelation between start codon polymorphism of thevitamin D receptor gene and bone mineral density inpremenopausal French women: the OFELY study // J.Bone Miner. Res. – 1998. – 13, № 1. – P.31–35.
  20. 20. Eisman J.A. Genetics of osteoporosis // Endocrine Rev. –2000. – 20, № 6. – P.788–804.
  21. Eriksen E.F., Langdahl B., Vesterby A. et al. Hormonereplacement therapy prevents osteoclastic hyperac-tivity: a histomorphometric study in early postmeno-pausal women // J. Bone Miner. Res. – 1999. – 14,№ 7. – P.1217–1221.
  22. Ferrari S.L., Garnero P., Emond S. et al. A functionalpolymorphic variant in the interleukin-6 gene promoterassociated with low bone resorption in postmenopausalwomen // Arthritis Rheum. – 2001. – 44, № 1. – P.196–201.
  23. Gennari L., Becherini L., Masi L. et al. Vitamin D andestrogen receptor allelic variants in Italian postmeno-pausal women: evidence of multiple gene contributionto bone mineral density // J.Clin.Endocrinol.Metab. –1998. – 83, № 2. – P.939–944.
  24. Giacconi R., Cipriano C., Albanese F.C.A. The 174G/C polimorphism of IL-6 is useful to screen old sub-jects at risk for atherosclerosis or to reach successfulageing // Exp. Gerontol. – 2004. – 39, № 4. – P.621–628.
  25. Grey A., Mitnick M.A., Masiukiewicz U. et al. A roleof interleukin-6 in parathyroid hormone-induced boneresorption in vivo // Endocrinology. – 1999. – 140,№ 5. – P.4683–4690.
  26. Guillйn C., Martнnez P., de Gortбzar A.R. et al. BothN- and C-terminal domains of parathyroid hormone-related protein increase interleukin-6 by nuclear Fac-tor-кB activation in osteoblastic cells // J. Biol. Chem. –2002. – 277, № 10. – P.28109–28117.
  27. Hofbauer L.C., Khosla S., Dunstan C.R. et al. Estro-gen stimulates gene expression and protein productionof osteoprotegerin in human osteoblastic cells // Endo-crinology. – 1999. – 140. № 5. – P.4367–4370.
  28. Hofbauer L.C., Gori F., Riggs B.L. et al. Stimulation ofosteoprotegerin ligand and inhibition of osteoprotegerinproduction by glucocorticoids in human osteoblasticlineage cells: potential paracrine mechanisms of gluco-corticoid-induced osteoporosis // Endocrinology. –1999. – 140, № 5. – P.4382–4389.
  29. 29. Johnson M.L., Gong G., Kimberling W. et al. Linkagof a gene causing high bone mass to human chromosome11 (11q12–13) // Amer. J. Hum. Genet. – 1997. – 60,№ 4. – P.1326–1332.
  30. 30. Kiel D.P., Cupples L.A., Myers R.H. et al. Bone mineraldensity (BMD), hip fracture and apolipoprotein E(ApoE) genotype // Bone. – 1998. – 23, Suppl.5. – P.S278.
  31. Klein R.F., Mitchell S.R., Phillips T.J. et al. Quantita-tive trait loci affecting peak bone mineral density inmice // J. Bone Miner. Res. – 1998. – 13, № 10. –P.1648–1656.
  32. Krabbe K.S., Pedersen M., Bruwnsgaard H. Inflamma-tory mediators in the elderly // Exp. Gerontol. – 2004. –39, № 5. – P.687–699.
  33. Krall E.A., Dawson-Hughes B. Soft tissue bodycomposition: familial resemblance and independentinfluences on bone mineral density // J. Bone Miner.Res. – 1995. – 10, № 12. – P.1944–1950.
  34. Langdahl B.L., Knudsen J.Y., Jensen H.K. et al. A se-quence variation: 713–8delC in the transforming growthfactor-beta 1 gene has higher prevalence in osteoporoticwomen than in normal women and is associated withvery low bone mass in osteoporotic women and in-creased bone turnover in both osteoporotic and normalwomen // Bone. – 1997. – 20, № 1. – P.289–294.
  35. Langdahl B.L., Ralston S.H., Grant S.F., Eriksen E.F.An Sp1 binding site polymorphism in the COLIA1gene predicts osteoporotic fractures in both men andwomen // J. Bone Miner. Res. – 1998. – 13, № 8. –P.1384–1389.
  36. Lin S.C., Yamate T., Taguchi Y. et al. Regulation of thegp80 and gp130 subunits of the IL-6 receptor by sexsteroids in the murine bone marrow // J. Clin. Invest. –1997. – 100, № 8. – P.1980–1990.
  37. Manolagas S.C., Weinstein R.S. New developments inthe pathogenesis and treatment of steroid – inducedosteoporosis // J. Bone Miner. Res. – 1999. – 14, № 6. –P.1061–1066.
  38. Manolagas S.C. Birth and death of bone cells: basicregulatory mechanisms and implications for thepathogenesis and treatment of osteoporosis // EndocrineRev. – 2000. – 21, № 2. – P.115–137.
  39. 39. Manolagas S.C. Estrogen Loss, Cytokines, Macroph-ages, Lymphocytes, Osteoclasts and Bone Loss: SixCharacters in Search of an Author or an Endocrine-Immune System Relay Causing Osteoporosis? // IBMSBoneKEy. – 2002. – 1, № 10. – P.200–212.
  40. 40. Martin T.J., Udagawa N. Hormonal regulation of os-teoclast function // Trends Endocrinol. Metab. – 1998. –9, № 1. – P.6–12 .
  41. Masi L., Becherini L., Colli E. et al. Polymorphisms ofthe calcitonin receptor gene are associated with bonemineral density in postmenopausal Italian women //Biochem. Biophys. Res. Commun. – 1998. – 248, № 1. –P.190–195.
  42. McClure L., Eccleshall T.R., Gross C. et al. Vitamin Dreceptor polymorphisms, bone mineral density, andbone metabolism in postmenopausal Mexican-Americanwomen // J. Bone Miner. Res. – 1997. – 12, № 1. –P.234–240.
  43. van Meurs J.B.J., Schuit S.C.E., Weel E.A.M. et al.Association of 5' estrogen receptor alpha gene poly-morphisms with bone mineral density, vertebral bonearea and fracture risk // Human Mol. Gen. – 2003. –12, № 14. – P.1745–1754.
  44. Mocharla H., Butch A.W., Pappas A.A. et al. Quanti-fication of vitamin D receptor mRNA by competitivepolymerase chain reaction in PBMC: lack of correspon-dence with common allelic variants // J. Bone Miner.Res. – 1997. – 12, № 5. – P.726–733.
  45. Morrison N.A., Yeoman R., Kelly P.J., Eisman J.A.Contribution of trans-acting factor alleles to normalphysiological variability: vitamin D receptor gene poly-morphism and circulating osteocalcin // Proc. Natl.Acad. Sci. USA. – 1992. – 89, № 5. – P.665–669.
  46. Okazaki R., Inoue D., Shibata M. et al. Estrogen Pro-motes Early Osteoblast Differentiation and InhibitsAdipocyte Differentiation in Mouse Bone MarrowStromal Cell Lines that Express Estrogen Receptor(ER) or Я // Endocrinology. – 2002. – 143, № 3. –P.2349–2356.
  47. Ota N., Hunt S.C., Nakajima T. et al. Linkage of humantumor necrosis factor- alpha to human osteoporosisby sib pair analysis // Genes. Immun. – 2000. – 1, № 4.– P.260–264.
  48. Ota N., Nakajima T., Nakazawa I. et al. A nucleotidevariant in the promoter region of the interleukin-6 geneassociated with decreased bone mineral density // J.Hum. Genet. – 2001. – 46, № 5. – P.267–272.
  49. 49. Pfeilschifter J., Kцditz R., Pfohl M., Schatz H. Changesin Proinflammatory Cytokine Activity after Menopau-se // Endocrinol. Rev. – 2002. – 23, № 1. – P.90–119.
  50. 50. Pluijm S.M.F., van Essen H.W., Bravenboer N. Collagentype I 1 Sp1 polymorphism, osteoporosis, and inter-vertebral disc degeneration in older men and women //Annals Rheum. Dis. – 2004. – 63, № 1. – P.71–77.
  51. Poli V., Balena R., Fattori E. et al. Interleukin-6 defi-cient mice are protected from bone loss caused by es-trogen depletion // EMBO J. – 1994. – 13, № 10. –P.1189–1196.
  52. Van Pottelbergh I., Goemaere S., Kaufman J. M.Bioavailable Estradiol and an Aromatase Gene Poly-morphism Are Determinants of Bone Mineral DensityChanges in Men over 70 Years of Age // J. Clin.Endocrinol. Metab. – 2003. – 88, № 7. – P.3075–3081
  53. Prevention and management of osteoporosis // WHO –Geneva, 2003. – 192 P.
  54. Ralston S.H. Genetic Control of Susceptibility to Os-teoporosis // J. Clin. Endocrinol. Metab. – 2002. – 87,№ 6. – P.2460–2466 .
  55. Rivadeneira F., Houwing – Duistermaat J.J., VaessenN. Association between an Insulin – Like Growth Fac-tor I Gene romoter Polymorphism and Bone MineralDensity in the Elderly: The Rotterdam Study // J. Clin.Endocrinol. Metab. – 2003. – 88, № 8. – P.3878–3884.
  56. Schoppet M., Preissner K.T., Hofbauer L.C. RANKligand and osteoprotegerin paracrine regulators of boneand vascular function // Arterioscl. Thromb.Vasc. Biol. – 2002. – 22, № 4. – P.549–555.
  57. Schuit S.C.E., van Meurs J.B.J., Bergink A.P. Heightin Pre- and Postmenopausal Women Is Influenced byEstrogen Receptor Gene Polymorphisms // J. Clin.Endocrinol. Metab. – 2004. – 89, № 1. – P.303–309.
  58. Schulte C.M., Dignass A.U., Goebell H. et al. Geneticfactors determine extent of bone loss in inflammatorybowel disease // Gestroenterology. – 2000. – 119, № 4.– P.909–1020.
  59. 59. Seeman E., Tsalamandris C., Formica C. et al. Reducedfemoral neck bone density in the daughters of womenwith hip fractures: the role of low peak bone densitythe pathogenesis of osteoporosis // J. Bone Miner.Res. – 1994. – 9, № 5 – P.739–743.
  60. 60. Seeman E. Physiology of Aging Invited Review: Patho-genesis of osteoporosis // J. Appl. Physiol. – 2003. –95, № 12 – P.2142–2151.
  61. Shi X.M., Chang Z.J., Blair H.C. et al. Glucocorti-coids induce adipogenesis of stromal cells by tran-scriptionally activating PPARy2 // Bone. – 1998. – 23,№ 6. – P.S454.
  62. Shimizu M., Higuchi K., Bennett B. et al. Identifica-tion of peak bone mass QTL in a spontaneously os-teoporotic mouse strain // Mamm. Genome. – 1999. –10, № 1. – P.81–87.
  63. Sowers M.F., Jannausch M.L., Liang W., Willing M.Estrogen Receptor Genotypes and Their Associationwith the 10-Year Changes in Bone Mineral Densityand Osteocalcin Concentrations // J. Clin. Endocrinol.Metab. – 2004. – 89, № 2. – P.733–739 .
  64. Sutton A.L.M., MacDonald P.N. Minireview VitaminD: More Than a «Bone-a-Fide» Hormone // Mol.Endocrinol. – 2003. – 17, № 5. – P.777–791 .
  65. Takacs I., Koller DL., Peacock M. et al. Sib pair link-age and association studies between bone mineral den-sity and the interleukin-6 gene locus // Bone. – 2000. –27, № 1. – P.169–173.
  66. Tomkinson A., Gevers E.F., Wit J.M. et al. The role ofestrogen in the control of rat osteocyte apoptosis // J.Bone Miner. Res. – 1998. – 13, № 8. – P.1243–1250.
  67. Uitterlinden A.G., Burger H., Huang Q. et al. Relationof alleles of the collagen type Ialpha1 gene to bonedensity and the risk of osteoporotic fractures in post-menopausal women // N. Engl. J. Med. – 1998. – 338,№ 5. – P.1016–1021.
  68. Yamada Y., Ando F., Niino N., Shimokata H. Associa-tion of Polymorphisms of Interleukin-6, Osteocalcin,and Vitamin D Receptor Genes, Alone or in Combina-tion, with Bone Mineral Density in Community-Dwell-ing Japanese Women and Men // J. Clin. Endocrinol.Metab. – 2003. – 88, № 7. – P.3372–3378.
  69. 69. Yokoyama K., Shigematsu T., Tsukada T. et al. ApaIin the vitamin D receptor gene mayaffect the parathyroid response in Japanese with end-stage renal disease // Kidney Int. – 1998. – 53, № 2. –P.454–458.
  70. 70. Willing M., Sowers M., Aron D. et al. Bone mineraldensity and its change in white women: estrogen andvitamin D receptor genotypes and their interaction //J. Bone Miner. Res. – 1998. – 13, № 4. – P.695–705.
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.